PALB2 and breast carcinoma: In our study, 152 specimen of patients with hereditary predisposition to breast cancer (including patients with early-onset breast cancer, family history of breast or ovarian cancer, bilateral cancer, or male breast cancer) were studied for PALB2 mutations.